Loading

Cialis Soft Tabs

By X. Julio. Dakota Wesleyan University.

Read some of the most common myths about rape and facts refuting the misconceptions below:Myth: Lust and the need for sexual gratification controls rapists behaviorsFact: Rape is never about sex or desire order cialis soft tabs 20mg with amex, but is completely motivated by a need for dominance buy generic cialis soft tabs 20 mg, power generic 20 mg cialis soft tabs with mastercard, and control. Myth: Women frequently falsely accuse innocent men of rape. Fact: False reports comprise 2 percent or less of reported incidents of rape. The percentage is likely even lower than 2 percent because fewer than one in 10 sexual assaults actually get reported. Myth: Women ask for rape if they dress provocatively or are overly good looking. Fact: Rapists select victims by evaluating their accessibility and vulnerability. Myth: Most sexual assault perpetrators choose strangers for their victims. Myth: Women who get raped while drunk, out alone at night, or overly flirtatious got what was coming to them. Fact: People who are drunk cannot consent to sex, making any sexual activity with them non-consensual and, thus, rape. Women who venture out alone at night or engage in the age-old practice of flirting do not deserve rape. Myth: Once a man gets aroused, he has lost the ability to stop himself from moving forward with sexual intercourse. Fact: Studies show that sexual assaults are either wholly or partially planned in advance. Men can easily control their urge to have sex, even at the height of arousal. Rape has nothing to do with the desire or need for sexual intercourse. Myth: Women usually get lubricated vaginally during rape and that means women love being raped. Fact: Recent research conducted by Kelly Suschinsky and Martin Lalumiere, show proof that vaginal lubrication occurs during both consensual and unwanted sex, such as in sexual assault. The study shows that while an erection does indicate sexual arousal in men, sexual arousal in women requires a complex mix of intimate connection, physical stimuli, and emotional presence. Rape is no joke and careless commentary about the topic only adds to the torment suffered by victims. It involves a person (typically a woman) imagining a scenario in which a stranger physically forces or coerces her into sex. Men have these rape fantasies too, but to a lesser extent, and they are most often the one forcing the sex on a woman feigning resistance. More recent analyses of 20 studies place that number as high as 57 percent for women and about 48 percent for heterosexual males. Studies by other human sexuality researchers count these fantasies as within the range of normal sexuality. Researchers unequivocally insist that these fantasies do not, in any way, indicate that a woman has a fantasy of being raped in real life. Frequently, women use rape fantasy to experience the edge of imaginative limits ??? to get a thrill and experience forced submission in a controlled, safe environment. They hide their sexual imaginations because they feel conflicted in fantasizing about something that would cause debilitating trauma in real life. Women need not guard their ravishment fantasies so closely now. Human sexuality experts emphatically state that rape fantasy is not wrong, but healthy and normal. They emphasize that the participants must agree on the boundaries and what will transpire during the role-play prior to the act. Most recommend agreeing upon a safe-word that, when spoken, will halt all activity immediately. Consensual agreement, despite feigned resistance during the acting out of the fantasy, is key to keeping things safe for both involved. Common fantasies for women with a theme of forced sex involve an audacious, somewhat arrogant, but incredibly handsome man sexually coercing her at home. Rape fantasy play can allow her to "resist" and say "no" to intense sex that her socialization forbids, yet still experience it. Feel irresistible ??? Women may want to feel so attractive that even a normally innocent handy man at her home simply cannot resist the urge to touch her and ravish her body. Thrill and chill of fear ??? Even though the role-play is planned and consensual, some women can suspend their disbelief to the point of experiencing a certain level of fear that feels thrilling.

cialis soft tabs 20mg visa

Reduction in fasting plasma glucose was comparable between treatment groups (see Table 4) purchase cialis soft tabs 20 mg with visa. Table 4: Results of Two 24-Week discount cialis soft tabs 20 mg free shipping, Active-Control cialis soft tabs 20 mg on line, Open-Label Trials in Patients With Type 2 Diabetes Previously On Oral Agent Therapy (Studies E and F)* SU = sulfonylurea, Met = metformin, Gli = glibenclamide?-P Low stratum = entry HbA1c ?-U8. See DOSAGE AND ADMINISTRATION Patients with end-of-study HbAExubera is indicated for the treatment of adult patients with diabetes mellitus for the control of hyperglycemia. Exubera has an onset of action similar to rapid-acting insulin analogs and has a duration of glucose-lowering activity comparable to subcutaneously administered regular human insulin. In patients with type 1 diabetes, Exubera should be used in regimens that include a longer-acting insulin. In patients with type 2 diabetes, Exubera can be used as monotherapy or in combination with oral agents or longer-acting insulins. Exubera is contraindicated in patients hypersensitive to Exubera or one of its excipients. Exubera is contraindicated in patients who smoke or who have discontinued smoking less than 6 months prior to starting Exubera therapy. If a patient starts or resumes smoking, Exubera must be discontinued immediately due to the increased risk of hypoglycemia, and an alternative treatment must be utilized (see CLINICAL PHARMACOLOGY, Special Populations, Smoking ). The safety and efficacy of Exubera in patients who smoke have not been established. Exubera is contraindicated in patients with unstable or poorly controlled lung disease, because of wide variations in lung function that could affect the absorption of Exubera and increase the risk of hypoglycemia or hyperglycemia. Exubera differs from regular human insulin by its rapid onset of action. When used as mealtime insulin, the dose of Exubera should be given within 10 minutes before a meal. Hypoglycemia is the most commonly reported adverse event of insulin therapy, including Exubera. The timing of hypoglycemia may differ among various insulin formulations. Patients with type 1 diabetes also require a longer-acting insulin to maintain adequate glucose control. Any change of insulin should be made cautiously and only under medical supervision. Concomitant oral antidiabetic treatment may need to be adjusted. Glucose monitoring is recommended for all patients with diabetes. Because of the effect of Exubera on pulmonary function, all patients should have pulmonary function assessed prior to initiating therapy with Exubera (see PRECAUTIONS: Pulmonary Function). The use of Exubera in patients with underlying lung disease, such as asthma or COPD, is not recommended because the safety and efficacy of Exubera in this population have not been established (see PRECAUTIONS: Underlying Lung Disease). In clinical trials of Exubera, there have been 6 newly diagnosed cases of primary lung malignancies among Exubera-treated patients, and 1 newly diagnosed case among comparator-treated patients. There has also been 1 postmarketing report of a primary lung malignancy in an Exubera-treated patient. In controlled clinical trials of Exubera, the incidence of new primary lung cancer per 100 patient-years of study drug exposure was 0. There were too few cases to determine whether the emergence of these events is related to Exubera. All patients who were diagnosed with lung cancer had a prior history of cigarette smoking. As with all insulin preparations, the time course of Exubera action may vary in different individuals or at different times in the same individual. Adjustment of dosage of any insulin may be necessary if patients change their physical activity or their usual meal plan. Insulin requirements may be altered during intercurrent conditions such as illness, emotional disturbances, or stress. As with all insulin preparations, hypoglycemic reactions may be associated with the administration of Exubera. Rapid changes in serum glucose concentrations may induce symptoms similar to hypoglycemia in persons with diabetes, regardless of the glucose value. Early warning symptoms of hypoglycemia may be different or less pronounced under certain conditions, such as long duration of diabetes, diabetic nerve disease, use of medications such as beta-blockers, or intensified diabetes control (see PRECAUTIONS: Drug Interactions). Studies have not been performed in patients with renal impairment. As with other insulin preparations, the dose requirements for Exubera may be reduced in patients with renal impairment (see CLINICAL PHARMACOLOGY, Special Populations). Studies have not been performed in patients with hepatic impairment. As with other insulin preparations, the dose requirements for Exubera may be reduced in patients with hepatic impairment (see CLINICAL PHARMACOLOGY, Special Populations). In clinical studies, the overall incidence of allergic reactions in patients treated with Exubera was similar to that in patients using subcutaneous regimens with regular human insulin.

purchase cialis soft tabs 20 mg

Participants in clinical trials can play a more active role in their own health care cialis soft tabs 20mg on-line, gain access to new research treatments before they are widely available buy generic cialis soft tabs 20 mg, and help others by contributing to medical research generic cialis soft tabs 20 mg on-line. Sources: National Diabetes Information Clearinghouse, NIH Publication No 09-4805, November 2008National Diabetes Education ProgramPhone: 1-800-DIABETES (342-2383)National Diabetes Information ClearinghouseResearch shows that you prevent, delay and manage diabetes through lifestyle changes, weight loss and increased physical activity, along with diabetes medication, metaformin. The DPP also suggests that metformin can help delay the onset of diabetes. Participants in the lifestyle intervention group?those receiving intensive individual counseling and motivational support on effective diet, exercise, and behavior modification?reduced their risk of developing diabetes by 58 percent. This finding was true across all participating ethnic groups and for both men and women. Lifestyle changes worked particularly well for participants aged 60 and older, reducing their risk by 71 percent. About 5 percent of the lifestyle intervention group developed diabetes each year during the study period, compared with 11 percent of those in the placebo group. Participants taking metformin reduced their risk of developing diabetes by 31 percent. Metformin was effective for both men and women, but it was least effective in people aged 45 and older. Metformin was most effective in people 25 to 44 years old and in those with a body mass index of 35 or higher, meaning they were at least 60 pounds overweight. In the years since the DPP was completed, further analyses of DPP data continue to yield important insights into the value of lifestyle changes in helping people prevent type 2 diabetes and associated conditions. For example, one analysis confirmed that DPP participants carrying two copies of a gene variant, or mutation, that significantly increased their risk of developing diabetes benefited from lifestyle changes as much as or more than those without the gene variant. Another analysis found that weight loss was the main predictor of reduced risk for developing diabetes in DPP lifestyle intervention group participants. The authors concluded that diabetes risk reduction efforts should focus on weight loss, which is helped by increased exercise. Analyses of DPP data have added to the evidence that changes in diet and physical activity leading to weight loss are especially effective in helping reduce risk factors associated with both diabetes and cardiovascular disease, including high blood pressure and metabolic syndrome. A person with metabolic syndrome has several of a specific group of risk factors for developing diabetes and heart disease, such as having excess fat deposited around the waist, high triglyceride levels, and high fasting blood glucose levels. One analysis found that DPP participants in the lifestyle intervention group who did not have metabolic syndrome at the beginning of the study?about half of the participants?were less likely to develop it than those in the other groups. Another analysis of DPP data found that the presence of high blood pressure in DPP participants decreased in the lifestyle intervention group but increased in the metformin and placebo groups over time. Measures of triglyceride and HDL cholesterol levels also improved in the lifestyle intervention group. A third analysis found that levels of C-reactive protein and fibrinogen?risk factors for heart disease?were lower in the metformin and lifestyle intervention groups, with a larger reduction in the lifestyle group. In addition, one study focused on urinary incontinence in women who participated in the DPP. Women in the lifestyle intervention group who lost 5 to 7 percent of their body weight through dietary changes and exercise had fewer problems with urinary incontinence than women in the other study groups. The DPP showed that people at risk for developing diabetes can prevent or delay the onset of diabetes by losing a modest amount of weight through diet and exercise. DPP participants in the lifestyle intervention group reduced their risk of developing diabetes by 58 percent during the study. DPP participants who took the oral diabetes medication metformin also reduced their risk of developing diabetes, but not as much as those in the lifestyle intervention group. The DPP contributed to a better understanding of how diabetes develops in people at risk and how they can prevent or delay the development of diabetes by making behavioral changes leading to weight loss. These findings are reflected in recommendations from the American Diabetes Association for the prevention or delay of type 2 diabetes, which stress the importance of lifestyle changes and weight loss. DPP researchers continue to examine the roles of lifestyle and metformin and other diabetes medications in preventing type 2 diabetes. DPPOS is examining the impact of long-term risk reduction on diabetes-related health problems, such as nerve damage and heart, kidney, and eye disease. Participants in clinical trials can play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research. National Diabetes Information Clearinghouse, NIH Publication No. Several other devices for taking insulin are available and new approaches are under development. No matter which approach a person uses for taking insulin, consistent monitoring of blood glucose levels is important. Good blood glucose control can prevent complications of diabetes. Insulin pens provide a convenient, easy-to-use way of injecting insulin and may be less painful than a standard needle and syringe. Some of these devices use replaceable cartridges of insulin.

Contact Us

Name:

Email:

Inquiry Re:

Electrical
Solar
Power

Comments:

powered by alarm.com
Our Interactive Services, powered by Alarm.com, enable you to manage all of your systems—security, energy, and home automation—from your smartphone, computer, or web-enabled device (like an iPad).